Immediate Impact
1 from Science/Nature 51 standout
Citing Papers
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
Works of Luis Rivera being referenced
Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study
2017
Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Luis Rivera | 139 | 207 | 31 | 217 | 20 | 383 | |
| Thomas Seyler | 98 | 240 | 20 | 267 | 18 | 427 | |
| Phengta Vongphrachanh | 217 | 198 | 7 | 94 | 25 | 451 | |
| P. Chaud | 91 | 163 | 5 | 110 | 26 | 425 | |
| Maurício Antônio Pompilio | 242 | 187 | 9 | 81 | 33 | 429 | |
| Shuyun Xie | 219 | 173 | 13 | 141 | 41 | 438 | |
| Joel V. Chua | 162 | 167 | 5 | 178 | 20 | 398 | |
| Adriana S. Tan | 195 | 202 | 28 | 150 | 8 | 388 | |
| Birendra Prasad Gupta | 106 | 223 | 3 | 207 | 40 | 419 | |
| Stella Gikunju | 238 | 234 | 11 | 127 | 11 | 439 | |
| Jin Sun | 93 | 222 | 13 | 151 | 27 | 367 |
All Works
Login with ORCID to disown or claim papers
Loading papers...